HER2-low expression in patients with hormone receptor positive and HER2 negative advanced breast cancer treated with ribociclib or palbociclib in combination with endocrine therapy
Other, pp.255-262, 2025
- Publication Type: Other Publication / Other
- Publication Date: 2025
- Page Numbers: pp.255-262
- Acibadem Mehmet Ali Aydinlar University Affiliated: Yes